NO20050186L - Oligosakkaridbiomarkorer for mucopolysakkaridoser og andre beslektede forstyrrelser - Google Patents

Oligosakkaridbiomarkorer for mucopolysakkaridoser og andre beslektede forstyrrelser

Info

Publication number
NO20050186L
NO20050186L NO20050186A NO20050186A NO20050186L NO 20050186 L NO20050186 L NO 20050186L NO 20050186 A NO20050186 A NO 20050186A NO 20050186 A NO20050186 A NO 20050186A NO 20050186 L NO20050186 L NO 20050186L
Authority
NO
Norway
Prior art keywords
mps
oligosaccharide
target
solution
kit
Prior art date
Application number
NO20050186A
Other languages
English (en)
Norwegian (no)
Other versions
NO20050186D0 (no
Inventor
Peter John Meikle
Maria Fuller
Steve Lewis Ramsey
Enzo Ranieri
John Joseph Hopwood
Original Assignee
Womens & Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Womens & Childrens Hospital filed Critical Womens & Childrens Hospital
Publication of NO20050186D0 publication Critical patent/NO20050186D0/no
Publication of NO20050186L publication Critical patent/NO20050186L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, e.g. Konjac gum, Locust bean gum, Guar gum
    • G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20050186A 2002-06-14 2005-01-13 Oligosakkaridbiomarkorer for mucopolysakkaridoser og andre beslektede forstyrrelser NO20050186L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPS2930A AUPS293002A0 (en) 2002-06-14 2002-06-14 Identification of oligosaccharides and their use in the diagnosis and evaluation of mucopolysaccharidoses and other related disorders
PCT/AU2003/000731 WO2003106997A1 (en) 2002-06-14 2003-06-13 Oligosaccharide biomarkers for mucopolysaccharidoses and other related disorders

Publications (2)

Publication Number Publication Date
NO20050186D0 NO20050186D0 (no) 2005-01-13
NO20050186L true NO20050186L (no) 2005-03-10

Family

ID=3836492

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050186A NO20050186L (no) 2002-06-14 2005-01-13 Oligosakkaridbiomarkorer for mucopolysakkaridoser og andre beslektede forstyrrelser

Country Status (11)

Country Link
US (1) US20060286034A1 (de)
EP (2) EP2081023A3 (de)
JP (1) JP2005530157A (de)
AT (1) ATE467834T1 (de)
AU (2) AUPS293002A0 (de)
CA (1) CA2488811A1 (de)
DE (1) DE60332538D1 (de)
NO (1) NO20050186L (de)
NZ (1) NZ537512A (de)
TW (1) TW200400351A (de)
WO (1) WO2003106997A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4498918B2 (ja) 2002-04-30 2010-07-07 生化学工業株式会社 リソソーム病の検出方法
WO2004088322A1 (en) 2003-03-31 2004-10-14 Women's And Children's Hospital MULTIPLEX SCREENING FOR LYSOSOMAL STORAGE DISORDERS (LSDs)
US20070134666A1 (en) * 2003-10-27 2007-06-14 Hiroshi Kasai Simultneous analytical method for oxidatively damaged guanine compound and concentration correcting substance thereof, and analyzer used for this analytical method
JP2006047239A (ja) * 2004-08-09 2006-02-16 National Institute Of Advanced Industrial & Technology 硫酸化単糖の同定方法及び硫酸化単糖異性体混合物の分析方法
US20070161074A1 (en) * 2005-12-27 2007-07-12 Daiichi Pharmaceutical Co., Ltd. Diagnostic method of mucopolysaccharidoses
PT2245145T (pt) * 2008-01-18 2017-03-14 Biomarin Pharm Inc Fabrico de enzimas sulfatase lisossómicas humanas altamente fosforiladas e suas utilizações
JP2009229426A (ja) * 2008-03-25 2009-10-08 Sumitomo Bakelite Co Ltd 糖鎖分析法
US9793100B2 (en) 2008-07-23 2017-10-17 Samir Al Moussalami Portable plasma based diagnostic apparatus and diagnostic method
US8809009B2 (en) 2009-01-02 2014-08-19 Biomarin Pharmaceutical Inc. Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker
US9029530B2 (en) 2009-01-02 2015-05-12 Biomarin Pharmaceutical Inc. Detection of oligosaccharides
US8232073B2 (en) 2009-01-02 2012-07-31 Zacharon Pharmaceuticals, Inc. Quantification of non-reducing end glycan residual compounds
US8592140B2 (en) 2009-01-02 2013-11-26 Biomarin Pharmaceutical Inc. Detection of oligosaccharides
EP2776553B1 (de) * 2011-11-07 2018-07-11 Shire Human Genetic Therapies, Inc. Biomarker für das sanfilippo-syndrom und anwendungen davon
US9982288B2 (en) * 2014-04-30 2018-05-29 The Nemours Foundation Mucopolysaccharidosis IVA/VII screening and treatment method
MA40954A (fr) * 2014-11-14 2017-09-19 Shire Human Genetic Therapies Détermination de niveaux de glycosaminoglycane par spectrométrie de masse
CN107941963A (zh) * 2017-12-29 2018-04-20 珍奥集团股份有限公司 一种增加骨密度保健食品中盐酸氨基葡萄糖与硫酸软骨素的含量测定方法
CN116124971A (zh) * 2018-08-07 2023-05-16 江苏双林海洋生物药业有限公司 农产品中氨基葡萄糖含量的检测方法
CN108872441B (zh) * 2018-08-14 2021-09-03 江苏康缘药业股份有限公司 一种测定氨基葡萄糖和硫酸软骨素的方法
CN109781997A (zh) * 2019-01-22 2019-05-21 中国人民解放军总医院 用于诊断粘多糖病ⅱ型的生物标志物及其应用
CN114264741B (zh) * 2021-12-15 2022-08-19 山东大学 一种鉴别猪来源肝素是否掺反刍类动物肝素的方法
IT202200007808A1 (it) 2022-04-20 2023-10-20 Luigi Michele Pavone Composizioni terapeutiche per malattie causate da accumulo di eparan solfato
CN115032377B (zh) * 2022-08-11 2022-11-01 裕菁科技(上海)有限公司 一种粘多糖贮积症生物标记物及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5310646A (en) * 1988-05-13 1994-05-10 Regents Of The University Of Minnesota Method for the detection of mucopolysaccharide storage diseases
US5310464A (en) 1991-01-04 1994-05-10 Redepenning Jody G Electrocrystallization of strongly adherent brushite coatings on prosthetic alloys
US6506384B1 (en) * 1997-12-31 2003-01-14 New York University Early detection of mycobacterial disease
NZ337946A (en) * 1998-09-25 2001-11-30 Tokyo Gas Co Ltd C-13 labelled oligosaccharides and polysaccharides useful as diagnostic agents for pancreatic exocrine function
RU2196988C2 (ru) * 2000-04-19 2003-01-20 Государственный новосибирский областной клинический диагностический центр Способ диагностики мукополисахаридозов
MXPA02012032A (es) * 2000-06-07 2003-04-25 Univ Duke Metodos de diagnostico de la enfermedad de pompe y otras enfermedades por almacenamiento de glucogeno.
GB0128498D0 (en) * 2001-11-28 2002-01-23 Inst Of Child Health International standards for sphingolipids

Also Published As

Publication number Publication date
CA2488811A1 (en) 2003-12-24
AUPS293002A0 (en) 2002-07-04
EP1532438A4 (de) 2006-12-06
EP1532438B1 (de) 2010-05-12
AU2003233255B2 (en) 2009-02-19
NZ537512A (en) 2006-09-29
AU2003233255A1 (en) 2003-12-31
EP2081023A3 (de) 2009-10-07
ATE467834T1 (de) 2010-05-15
AU2003233255C1 (en) 2009-07-16
US20060286034A1 (en) 2006-12-21
WO2003106997A1 (en) 2003-12-24
JP2005530157A (ja) 2005-10-06
DE60332538D1 (de) 2010-06-24
EP2081023A2 (de) 2009-07-22
TW200400351A (en) 2004-01-01
NO20050186D0 (no) 2005-01-13
EP1532438A1 (de) 2005-05-25

Similar Documents

Publication Publication Date Title
NO20050186L (no) Oligosakkaridbiomarkorer for mucopolysakkaridoser og andre beslektede forstyrrelser
ATE535535T1 (de) Methoden für die diagnose von demenz und anderen neurologischen erkrankungen
US20090011452A1 (en) Method of Prognosis of Mental Diseases, E.G. Autism and Cerebral Palsy
RU2008103988A (ru) Способ диагностики рассеяного склероза
EA199900813A1 (ru) Прогнозирование ишемической болезни сердца
WO2004046729A3 (en) Bodily fluid markers of tissue hypoxia
JP2010539490A5 (de)
JP2009529884A (ja) ジペプチジルペプチダーゼ関連の疾患状態の診断および予後
DK1043587T3 (da) Fremgangsmåde til undersøgelse af nyresygdomme
DE60232595D1 (de) Methode zur diagnose von nierenerkrankungen
DE60025170D1 (de) Diagnostisches verfahren für asthma
JP2009537797A (ja) 神経変性疾患の診断及び早期診断のためのｉｎｖｉｔｒｏ方法
JP6592628B1 (ja) 脂肪性肝疾患の検出又はリスクの予測方法、脂肪性肝疾患を検出するための診断薬キット及びバイオマーカー、対象の肝線維化の進行度の判定方法、並びに対象の肝線維化の進行度を判定するためのバイオマーカー
JP2020064055A (ja) 脂肪性肝疾患の検出又はリスクの予測方法、脂肪性肝疾患を検出するための診断薬キット及びバイオマーカー、対象の肝線維化の進行度の判定方法、並びに対象の肝線維化の進行度を判定するためのバイオマーカー
US20160258961A1 (en) Novel phenyl glyoxal probes
JP2009210469A (ja) 血清たんぱく質の解析法
RU2157528C1 (ru) Способ прогнозирования злокачественных новообразований
Trojanowski Searching for the biomarkers of Alzheimer’s
JP4464298B2 (ja) 尿中のｎ２，ｎ２−ジメチルグアノシン濃度測定による心疾患の診断方法
ATE237276T1 (de) Automatisches diagnosesystem zur durchführung von immunoassays und klinisch-chemischen assays nach einem reflexalgorithmus
RU2206096C2 (ru) Способ диагностики активности воспалительного процесса при хроническом бронхите
SU786990A1 (ru) Способ дифференциальной диагностики рассе нного склероза и опухолей центральной нервной системы
WO2010087991A2 (en) Methods for diagnosing impending joint failure
JPWO2020044497A1 (ja) Ｎａｆｌｄ又はｎａｓｈの検出又はリスクの予測方法、ｎａｆｌｄ又はｎａｓｈを検出するための診断薬キット、対象における肝線維化の進行度の判定方法、及び対象における肝線維化の進行度を判定するための診断薬キット
RU2002117247A (ru) Способ скринингового обследования пациентов с помощью тест-системы ELI-Ren для диагностики и прогноза заболеваний органов мочевой системы

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application